Compass Pathways' delayed phase 3 readout for its psilocybin treatment has hit its primary endpoint of reducing the severity of patients’ depression, but investors appear unimpressed. The study ...
Investment bank Compass Point downgraded MARA Holdings (MARA) to a sell rating from neutral on Tuesday, citing unsustainable cash burn. “There's better ways to get BTC beta,” analysts wrote in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback